Study on the Efficacy of Quercetin Intake in Patients With Fibrotic Interstitial Lung Diseases.

NCT07466420 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Fibrotic Interstitial Lungs Diseases
Idiopathic Pulmonary Fibrosis (IPF)
Progressive Pulmonary Fibrosis

Interventions

DIETARY_SUPPLEMENT: Quercetin (dietary supplement)
DRUG: Usual treatment

Sponsor

Katerina M. Antoniou